Advertisement
News
Advertisement

Boston researchers test treatment for autism link

Fri, 12/17/2010 - 9:32am
Mass High Tech: The Journal of New England Technology

Children’s Hospital Boston scientists have initiated a clinical trial to test a potential treatment for Rett Syndrome, known to cause autism in girls.

The three-year trial will test mecasermin, a drug candidate that the U.S. Food and Drug Administration has already approved for IGF-1 deficiency-linked shortness. Forty girls diagnosed with Rett syndrome will participate in the trial, which will randomly assign placebo or mecasermin. The research team will study the results based on neurodevelopment and cardiorespiratory outcomes.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading